| BRKC | QYLD | BRKC / QYLD | |
| Gain YTD | -1.664 | 10.124 | -16% |
| Net Assets | 16.7M | 8.36B | 0% |
| Total Expense Ratio | 1.01 | 0.60 | 168% |
| Turnover | N/A | 24.46 | - |
| Yield | 10.93 | 9.88 | 111% |
| Fund Existence | 1 year | 13 years | - |
| BRKC | QYLD | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 40% | 3 days ago 43% |
| Stochastic ODDS (%) | 3 days ago 89% | 3 days ago 58% |
| Momentum ODDS (%) | 3 days ago 77% | 3 days ago 88% |
| MACD ODDS (%) | 3 days ago 75% | 3 days ago 81% |
| TrendWeek ODDS (%) | 3 days ago 79% | 3 days ago 78% |
| TrendMonth ODDS (%) | 3 days ago 79% | 3 days ago 82% |
| Advances ODDS (%) | 19 days ago 70% | 3 days ago 80% |
| Declines ODDS (%) | 3 days ago 72% | 26 days ago 71% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 44% |
| Aroon ODDS (%) | 3 days ago 90% | 6 days ago 83% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 32.53 | 0.42 | +1.30% |
| Fidelity Disruptive Medicine ETF | |||
| IDVZ | 34.91 | 0.28 | +0.80% |
| Polen International Div Inc ETF | |||
| MSSM | 60.75 | 0.48 | +0.79% |
| Morgan Stanley Pathway Sm-Md Cp Eq ETF | |||
| RHTX | 20.30 | N/A | N/A |
| RH Tactical Outlook ETF | |||
| IAGG | 49.77 | -0.02 | -0.04% |
| iShares Core International Aggt Bd ETF | |||
A.I.dvisor indicates that over the last year, QYLD has been closely correlated with LRCX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if QYLD jumps, then LRCX could also see price increases.
| Ticker / NAME | Correlation To QYLD | 1D Price Change % | ||
|---|---|---|---|---|
| QYLD | 100% | +0.49% | ||
| LRCX - QYLD | 66% Closely correlated | +1.12% | ||
| KLAC - QYLD | 64% Loosely correlated | -1.01% | ||
| AMAT - QYLD | 63% Loosely correlated | -0.78% | ||
| ASML - QYLD | 62% Loosely correlated | +0.77% | ||
| TSLA - QYLD | 57% Loosely correlated | +5.14% | ||
More | ||||